“The whole concept of senior living will change,” CNBC’s Jim Cramer said Tuesday, discussing the news that Biogen and Eisai plan to seek regulatory approval of their investigational treatment for early Alzheimer’s disease, aducanumab.
A Florida company must stop marketing its unapproved cannabidiol products using unsubstantiated claims that the products treat Parkinson’s disease, Alzheimer’s disease and other conditions, the Food and Drug Administration and Federal Trade Commission said in a warning letter released Tuesday.
Four former U.S. surgeons general are advocating for regular annual cognitive assessments as part of routine check-ups, calling dementia the No. 1 public health crisis.
Days before World Alzheimer’s Day, which was Saturday, some bad news arrived about the search for a treatment. But there still are reasons for hope in the battle against Alzheimer’s.
Exercising several times a week may delay brain deterioration in those who are at high risk of Alzheimer’s disease, according to a study published in the Journal of Alzheimer’s Disease.
A “novel, simple and fast-acting” cure for Alzheimer’s disease would be a “medical miracle” but would result in a loss of $16.3 billion in annual revenues for the assisted living industry, according to a new analysis published in the journal Medical Hypotheses.
Oct. 7 is deadline to comment on U.S. Preventive Services Task Force draft statement on cognitive screening … ‘Revolutionary’ $53 million grant to fund 40 pilots to improve direct Alzheimer’s care … Mediterranean diet linked to lower cognitive decline in U.S. seniors
Time is running out to support Alzheimer’s disease research and care through the purchase of a special stamp via the U.S. Postal Service.
There are several reasons that I don’t believe Alzheimer’s care is where it should be. Here are six.
When residents begin to take more naps, it might not just be that they are tired. New research indicates it might be an early warning sign of advancing Alzheimer’s disease.
